You are here

  • Home
  • Archive
  • Volume 103, Issue 1
  • Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies

Article metrics

Article menu

Download PDFPDF

Clinical science
Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies

 

Online download statistics by month:

Online download statistics by month: March 2018 to March 2024

AbstractFullPdf
Mar 201837738980
Apr 2018566585138
May 201841745655
Jun 201819119654
Jul 201816216250
Aug 201813713734
Sep 201812312347
Oct 2018818240
Nov 201810010036
Dec 201842341770
Jan 201926725670
Feb 20199788266
Mar 2019806935
Apr 2019695539
May 2019767541
Jun 2019736830
Jul 2019636332
Aug 2019626032
Sep 2019696633
Oct 2019797230
Nov 2019747025
Dec 2019645513
Jan 2020615728
Feb 2020615828
Mar 2020525124
Apr 2020848138
May 2020666221
Jun 2020646022
Jul 2020656316
Aug 2020555428
Sep 2020696624
Oct 2020595621
Nov 2020322939
Dec 2020715832
Jan 2021292418
Feb 2021343030
Mar 2021343320
Apr 2021171613
May 2021323123
Jun 2021393928
Jul 202116157
Aug 2021312816
Sep 2021312817
Oct 2021282740
Nov 2021403640
Dec 2021232216
Jan 2022322525
Feb 2022262825
Mar 2022454032
Apr 2022464725
May 2022545732
Jun 2022626121
Jul 202229286
Aug 2022494819
Sep 2022525232
Oct 2022464320
Nov 2022424213
Dec 2022333321
Jan 2023403612
Feb 2023474413
Mar 2023423519
Apr 2023322215
May 2023292418
Jun 2023403611
Jul 2023232218
Aug 2023353616
Sep 2023888610
Oct 202320519914
Nov 20232842857
Dec 2023343214
Jan 202440409
Feb 2024473815
Mar 2024282841
Total627361352342